Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Añadir filtros








Intervalo de año
1.
Gastroenterology and Hepatology from Bed to Bench. 2017; 10 (4): 272-277
en Inglés | IMEMR | ID: emr-190563

RESUMEN

Aim: To evaluate the baseline expression of the immune genes in PBMCs of responder and non-responder patients with chronic Hepatitis C


Background: Although the contribution of peripheral blood mononuclear cell [PBMC] gene expression in treatment outcome of hepatitis C virus [HCV] infection is supposed, it has remained to be distinctly delineated. The baseline expression of the immune genes inside PBMCs may reflect the responsiveness status following IFN treatment


Methods: Totally, 22 chronic HCV encompasses 10 responders and 12 non-responsive cases enrolled randomly regarding medical records. The PBMCs from the peripheral blood samples were isolated and then incubated for 6 hours in the culture media. The baseline expression of TLR7, SOCS1 and ISG15 was measured by Real time PCR


Results: The gene expression pattern in PBMCs of both groups showed a similar trend. The expression of SOCS1 and TLR7 genes showed higher levels in non-responder group [P>0.05]. The result of ISG15 showed a higher but non-significant expression in the responder group [P>0.05]


Conclusion: The similar pattern of TLR7, SOCS1 and ISG15 expression in the responder and non-responder patients indicated their poor discriminating and predictive value in PBMCs sample

2.
Novelty in Biomedicine. 2014; 2 (1): 6-9
en Inglés | IMEMR | ID: emr-160680

RESUMEN

Measles, rubella, mumps, hepatitis B virus [HBV] and varicella zoster virus [VZV] cause infectious diseases that can be effectively prevented by vaccination. Vaccination of medical students is important, because they are more likely to become exposed and infected by these viruses. A total of 180 students, consisting of 90 women and 90 men, were serologically screened for measles, rubella and mumps, HBV and VZV antibodies. Their sera were examined for Immunoglobulin G [IgG] antibody against these viruses by using ELISA IgG kits. Total antibody against measles, rubella, mumps, HBV and VZV were 52%, 100%, 76%, 68% and 15% respectively. There was no significant difference in antibodies level according to gender. The results of this study indicate vaccination is vital for medical student prior to hospital training

3.
IJI-Iranian Journal of Immunology. 2010; 7 (2): 130-131
en Inglés | IMEMR | ID: emr-123709
4.
IJI-Iranian Journal of Immunology. 2010; 7 (1): 39-48
en Inglés | IMEMR | ID: emr-105823

RESUMEN

Pandemic flu had at least two waves in Iran. Knowing how many of the general population were already exposed to this infection has a major impact on national preventive measures. As of December 30, 2009, a total of 3672 confirmed cases of human infection with a novel Influenza A [2009 H1N1] virus had been reported in Iran with 140 deaths. In this study we aim to measure, as a pilot study, the seroprevalence of positive antibody titer [humoral immunity] against 2009 H1N1 virus in Iranian population in Shiraz, Southern Iran. Through cluster random sampling of families residing in Shiraz, 2553 subjects were selected and after a medical interview blood samples were taken and checked for polyclonal antibody against 2009 H1N1 antigen using hemagglutination inhibition assay. An antibody titer of more than 1:40 dilution was considered positive. Data were analyzed considering the demographic characteristics of the population and were compared among different age groups. 1504 [58.91%] samples were tested positive for the presence of polyclonal antibody against 2009 H1N1 virus. The prevalence of positive titers were significantly higher in 60 to 64 years old group and significantly lower in 20 to 24 years old group [p<0.05]. Data did not differ based on other demographic characteristics or the history of flu like illnesses in the past 6 months. High seroprevalence of antibody against 2009 H1N1 in the sera of our subjects describes either a high level of preexisting immunity against H1N1 in Iranian population or a high rate of asymptomatic infection in our area compared to other countries


Asunto(s)
Humanos , Masculino , Femenino , Pruebas de Inhibición de Hemaglutinación , Vacunas contra la Influenza , Inmunidad Humoral , Proyectos Piloto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA